A celebration of the inspirational figures behind innovation and achievement in pathology and laboratory medicine
08/18/2017 | Roisin McGuigan
An EHR-derived phenotypic disease catalog allows replication of decades of work on HLAs
07/21/2017 | Michael Schubert
CRISPR/Cas gene editing is a powerful, ever-evolving tool – but it seems to be here to stay…
07/21/2017 | Jegen Kandasamy
Research reveals a potential predictor of bronchopulmonary dysplasia risk in preterm infants
07/20/2017 | Guy Rutty and Bruno Morgan
When it comes to investigating death, we must first ask ourselves, “What is the question?”
07/20/2017 | Michael Schubert
A blood test that can predict treatment response and reveal evolving resistance in prostate cancer
06/26/2017 | Antonia R. Sepulveda
New collaborative guidelines for molecular biomarker testing in colorectal cancer
06/26/2017 | Roisin McGuigan
Two experts explain why they believe ctDNA analysis is the future of cancer pathology
George Calin, Professor, Department of Experimental Therapeutics, and Co-Director, The Center for RNA Interference and Non-coding RNAs, MD Anderson Cancer Center, USA
06/26/2017 | Andreas Hühmer
To win the war on cancer, we need to put proteomics on an equal footing with genomics
06/26/2017 | Tomonori Kimura
Chiral amino acids are now under the spotlight as biomarkers for kidney disease
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
Lessons from the Power List: Challenges
The Genome Pioneer
The Value of Neuropathology